Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients

NCT01308294 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Low enrollment rate

Conditions

Melanoma

Interventions

BIOLOGICAL: 2 vaccine injections in 1 limb
BIOLOGICAL: 2 vaccine injections in distinct limbs
BIOLOGICAL: 2 "vaccine injections" in distinct limbs

Sponsor

Centre Hospitalier Universitaire Vaudois

Collaborators

[object Object]